Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H32ClN3O5 |
InChIKeyGOPVDUORTYMGAL-JVVVGQRLSA-N |
CAS Registry3056257-39-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Austria | 05 Mar 2024 | |
| Neoplasms | Preclinical | Austria | 05 Mar 2024 |





